Sino Biopharm Ord (SBMFF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,331,129 | 1,335,550 | 1,793,040 | 1,638,166 | 1,631,441 |
| Marketable Securities | 699,351 | 439,873 | 721,519 | 721,640 | 629,195 |
| Receivables | 690,988 | 637,291 | 689,266 | 654,203 | 422,250 |
| Inventories | 330,105 | 281,678 | 346,066 | 300,350 | 272,419 |
| Other current assets | 41,119 | 155,616 | 56,876 | 62,739 | 0 |
| TOTAL | $3,433,729 | $3,363,721 | $3,853,927 | $3,642,993 | $3,302,880 |
| Non-Current Assets | |||||
| PPE Net | 1,208,971 | 1,141,832 | 1,153,075 | 1,108,916 | 995,505 |
| Investments And Advances | 2,398,050 | 2,655,817 | 2,912,313 | 3,239,982 | 1,625,108 |
| Intangibles | 425,780 | 411,036 | 284,487 | 265,352 | 146,876 |
| Other Non-Current Assets | 1,631,732 | 1,414,954 | 1,316,150 | 1,126,975 | 770,424 |
| TOTAL | $5,664,533 | $5,623,639 | $5,666,025 | $5,741,225 | $3,537,913 |
| Total Assets | $9,098,263 | $8,987,361 | $9,519,952 | $9,384,217 | $6,840,792 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,057,448 | 1,573,508 | 1,441,305 | 1,010,688 | 225,004 |
| Accounts payable and accrued liabilities | 1,613,445 | 1,536,839 | 1,511,716 | 1,342,117 | 1,347,761 |
| Other current liabilities | 1,213 | 1,723 | 16,421 | N/A | N/A |
| TOTAL | $2,720,308 | $3,194,337 | $2,994,391 | $2,378,478 | $1,585,719 |
| Non-Current Liabilities | |||||
| Long Term Debt | 277,748 | 149,488 | 584,572 | 64,067 | 1,003,014 |
| Other Non-Current Liabilities | -358,817 | -328,540 | -297,751 | 541,499 | 663,033 |
| TOTAL | $428,082 | $399,609 | $887,151 | $1,157,741 | $2,006,480 |
| Total Liabilities | $3,148,389 | $3,593,947 | $3,881,541 | $3,536,219 | $3,592,198 |
| Shareholders' Equity | |||||
| Common Shares | 57,641 | 58,585 | 61,654 | 64,393 | 60,263 |
| Retained earnings | 3,516,526 | 3,341,596 | 3,428,187 | 3,576,067 | 1,516,875 |
| Other shareholders' equity | 2,352,514 | 1,798,473 | 1,889,986 | 1,808,041 | 1,282,518 |
| TOTAL | $5,949,873 | $5,393,415 | $5,638,411 | $5,847,999 | $3,248,594 |
| Total Liabilities And Equity | $9,098,262 | $8,987,362 | $9,519,952 | $9,384,218 | $6,840,792 |